FRED HUTCHINSON CANCER CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Employees: -

Market Cap: -

Website: https://www.fredhutch.org

Clinical Trials

Diet and Metabolic Inflammation

Not Applicable

Completed

Conditions: Diabetes
Inflammation
Insulin Resistance
Obesity
Cancer

Interventions: Other: Diet B
Other: Diet A

First Posted Date: 2015-09-03

Last Posted Date: 2016-10-24

Lead Sponsor: Fred Hutchinson Cancer Center

Target Recruit Count: 16

Registration Number: NCT02539355

Locations: 🇺🇸
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States

Support Group Program in Improving Quality of Life in Underserved Urban Latina Breast Cancer Survivors

Not Applicable

Completed

Conditions: Breast Carcinoma
Cancer Survivor

Interventions: Other: Informational Intervention
Other: Quality-of-Life Assessment
Other: Questionnaire Administration
Procedure: Support Group Therapy

First Posted Date: 2015-08-13

Last Posted Date: 2018-10-05

Lead Sponsor: Fred Hutchinson Cancer Center

Target Recruit Count: 10

Registration Number: NCT02521961

Locations: 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

The Vaginal Health Trial

Phase 3

Completed

Conditions: Menopause
Atrophy of Vagina
Dyspareunia (Female)

Interventions: Device: Replens
Drug: Vagifem
Other: Placebo gel
Other: Placebo tablet

First Posted Date: 2015-08-05

Last Posted Date: 2018-07-12

Lead Sponsor: Fred Hutchinson Cancer Center

Target Recruit Count: 302

Registration Number: NCT02516202

Locations: 🇺🇸
Kaiser Permanente Washington Health Research Institute, Seattle, Washington, United States
🇺🇸
University of Minnesota, Minneapolis, Minnesota, United States

Ixazomib Citrate in Treating Patients With Chronic Graft-versus-Host Disease

Phase 2

Completed

Conditions: Chronic Graft Versus Host Disease

Interventions: Drug: Ixazomib Citrate
Other: Laboratory Biomarker Analysis
Other: Quality-of-Life Assessment
Other: Questionnaire Administration

First Posted Date: 2015-07-31

Last Posted Date: 2019-02-06

Lead Sponsor: Fred Hutchinson Cancer Center

Target Recruit Count: 50

Registration Number: NCT02513498

Locations: 🇺🇸
Moffitt Cancer Center, Tampa, Florida, United States
🇺🇸
University of Nebraska Medical Center, Omaha, Nebraska, United States
🇺🇸
UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States

and more 3 locations

Carfilzomib in Treating Patients With Chronic Graft-Versus-Host Disease

Phase 2

Completed

Conditions: Chronic Graft Versus Host Disease

Interventions: Drug: Carfilzomib
Other: Laboratory Biomarker Analysis
Other: Quality-of-Life Assessment
Other: Questionnaire Administration

First Posted Date: 2015-07-08

Last Posted Date: 2019-02-06

Lead Sponsor: Fred Hutchinson Cancer Center

Target Recruit Count: 20

Registration Number: NCT02491359

Locations: 🇺🇸
University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania, United States
🇺🇸
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
🇺🇸
Moffitt Cancer Center, Tampa, Florida, United States

and more 2 locations

Anti-CD20 Radioimmunotherapy Before Chemotherapy and Stem Cell Transplant in Treating Patients With High-Risk B-Cell Malignancies

Phase 1

Terminated

Conditions: Burkitt Lymphoma
CD20-Positive Neoplastic Cells Present
Indolent Non-Hodgkin Lymphoma
Refractory Mature B-Cell Non-Hodgkin Lymphoma
Mantle Cell Lymphoma
Recurrent B-Cell Non-Hodgkin Lymphoma
Diffuse Large B-Cell Lymphoma

Interventions: Biological: Anti-CD20 B9E9 scFv-Streptavidin Fusion Protein
Procedure: Autologous Hematopoietic Stem Cell Transplantation
Drug: Carmustine
Drug: Clearing Agent
Drug: Cytarabine
Drug: Etoposide
Radiation: Indium In 111-DOTA-Biotin
Other: Laboratory Biomarker Analysis
Drug: Melphalan
Procedure: Peripheral Blood Stem Cell Transplantation
Other: Pharmacological Study
Radiation: Yttrium Y 90-DOTA-Biotin

First Posted Date: 2015-06-26

Last Posted Date: 2020-11-23

Lead Sponsor: Fred Hutchinson Cancer Center

Target Recruit Count: 3

Registration Number: NCT02483000

Locations: 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

TREC Lifestyle Beyond Cancer Study in Endometrial Cancer Survivors

Not Applicable

Completed

Conditions: Endometrial Cancer

Interventions: Behavioral: Enhanced Usual Care Group (Arm C)
Behavioral: Telemedicine Weight Management plus Wi-Fi Scale (Arm A)
Behavioral: Text for Diet (Text4Diet) Group (Arm B)

First Posted Date: 2015-06-09

Last Posted Date: 2016-06-02

Lead Sponsor: Fred Hutchinson Cancer Center

Target Recruit Count: 207

Registration Number: NCT02466061

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States
🇺🇸
Dana Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸
Washington University in St Louis (Siteman Cancer Center), St. Louis, Missouri, United States

Diet and Exercise Program to Promote Weight Loss and Improve Health in Men With Low- or Low-Intermediate-Risk Prostate Cancer

Not Applicable

Terminated

Conditions: Prostate Adenocarcinoma
Stage IIA Prostate Cancer AJCC v7
Stage I Prostate Cancer AJCC V7

Interventions: Behavioral: Behavioral Dietary Intervention
Other: Informational Intervention
Behavioral: Exercise Intervention
Other: Laboratory Biomarker Analysis
Other: Questionnaire Administration
Other: Quality-of-Life Assessment

First Posted Date: 2015-05-27

Last Posted Date: 2023-01-04

Lead Sponsor: Fred Hutchinson Cancer Center

Target Recruit Count: 117

Registration Number: NCT02454517

Locations: 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

Women's Health Initiative Strong and Healthy Study

Not Applicable

Active, not recruiting

Conditions: Cardiovascular Mortality
Peripheral Artery Disease
Depressive Symptoms
Mortality
Stroke
Clinical (Non-hip) Fractures
Myocardial Infarction
Hip Fractures
Coronary Revascularization
Falls

Interventions: Behavioral: Physical Activity

First Posted Date: 2015-04-24

Last Posted Date: 2024-07-30

Lead Sponsor: Fred Hutchinson Cancer Center

Target Recruit Count: 49331

Registration Number: NCT02425345

Telephone-Delivered Interventions for Smoking Cessation

Not Applicable

Completed

Conditions: Smoking

Interventions: Behavioral: Telephone Delivered Intervention

First Posted Date: 2015-04-21

Last Posted Date: 2020-01-21

Lead Sponsor: Fred Hutchinson Cancer Center

Target Recruit Count: 1275

Registration Number: NCT02421991

Locations: 🇺🇸
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy